VO-OHpic structure
|
Common Name | VO-OHpic | ||
|---|---|---|---|---|
| CAS Number | 675848-25-6 | Molecular Weight | 361.16 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C12H10N2O8V | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of VO-OHpicVO-OHPic is a reversible, noncompetitive and selective PTEN inhibitor with an IC50 of 46 nM. VO-OHPic attenuates apoptosis, adverse cardiac remodeling, and pro-inflammatory M1 macrophages in doxorubicin-induced cardiomyopathy. VO-OHPic inhibits autophagy[1][2][3]. |
| Name | VO-OHpic |
|---|---|
| Synonym | More Synonyms |
| Description | VO-OHPic is a reversible, noncompetitive and selective PTEN inhibitor with an IC50 of 46 nM. VO-OHPic attenuates apoptosis, adverse cardiac remodeling, and pro-inflammatory M1 macrophages in doxorubicin-induced cardiomyopathy. VO-OHPic inhibits autophagy[1][2][3]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 46 nM (PTEN)[1] |
| References |
| Molecular Formula | C12H10N2O8V |
|---|---|
| Molecular Weight | 361.16 |
| InChIKey | DUQTXODYOYERFR-UHFFFAOYSA-N |
| SMILES | O=C(O)c1ncccc1O.O=C(O)c1ncccc1O.O=[V][O-] |
| (OC-6-45)-Aqua(3-hydroxy-2-pyridinecarboxylato-κ-N1,κO2)[3-(hydroxy-κO)-2-pyridinecarboxylato(2-)-κO2]oxovanadate(1-),hydrogen |